TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CELU

Celularity Inc

Healthcare · Biotechnology

1.20$ -4.8% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CELU
Line item 2018 2019 2020 2021 2022 2023 2024 2025
+2,110,617.6% -17.4% -3.9% -3.2% -64.1% -7.8% -19.1%
+148,869.9% +96.1% -48.4% -10.0% -40.9% +3.9% -40.1%
+113,746.3% +93.1% -31.4% -62.5% -98.4% +225.1% +736.7%
+113,746.3% +93.1% -31.4% -62.5% +736.7%
-21.5% +112.8% -20.1% +33.1% +44.2% +34.9% -65.7%
-8.6% +19.1% +148.0% -44.4% +8.4% -6.0% -89.4%
+1,555.1% +35.7% +0.6%
-2.7% -3.0% +0.0% -2.9% -93.9% +0.0% +0.0%
-31.0% -53.8% -1.7% -1.8% -90.9% -15.9% -16.1%
+254,712.5% +7.5% -23.7% -35.8% -49.1% +20.3% +17.4%
+13,606.0% +29.3% -1.7% +136.8% +8.4% -20.2% +50.4%
+1.4% +1,132.5% +120.1%
-99.6% +28,444.2% +72.9% -37.6% +143.4% +64.7% +13.4%
-86.4% +431.3% +100.1% -79.4% -78.4% -530.7%
-33.6% -22.8% +591.0% +17.7% +29.3% +13.0% +16.9%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?